by Mrudula Kulkarni

2 minutes

Bhavin Mehta Appointed Vice-Chairman of Pharmexcil

From Appointments | Pg 19

Bhavin Mehta Appointed Vice-Chairman of Pharmexcil
0

0

Read in FlipBook

Pharmexcil, India’s apex body for pharmaceutical export promotion, has appointed Bhavin Mukund Mehta, Wholetime Director of Kilitch Drugs (India) Limited, as its new Vice-Chairman. With over 25 years of experience, Mehta has played a crucial role in expanding Kilitch Drugs’ global footprint while strengthening its domestic market presence. His leadership in business development, strategy, and international marketing has made him a key figure in the industry.

A longtime advocate for India’s pharmaceutical sector, Mehta previously led Pharmexcil’s Exhibition Committee, launching IPHEX, the country’s largest pharmaceutical export trade show. Expressing gratitude for his new role, Mehta emphasized his commitment to strengthening India’s position as a global pharmaceutical leader while supporting MSME growth. With his expertise, Pharmexcil aims to unlock new trade opportunities and drive innovation in India’s pharmaceutical exports.

Comment your thoughts

12 Grids

Feb-Mar Edition

Navigating the Digital Frontier

Read More
12 Grids

Navigating the Digital Frontier

FEATURING

    • Global Industry Trends & Insights
    • Global Events & Conferences
    • Market Insights & Trends
    • "In Talks With Leadership" featuring Dr. Ashok Kumar Bhattacharya
    • SMART Practices to Take Assistance of Generative AI to Respond to FDA Warnings 
Read Now
12 Grids

Navigating the Digital Frontier

FEATURING

    • Global Industry Trends & Insights
    • Global Events & Conferences
    • Market Insights & Trends
    • "In Talks With Leadership" featuring Dr. Ashok Kumar Bhattacharya
    • SMART Practices to Take Assistance of Generative AI to Respond to FDA Warnings 
12 Grids

Feb-Mar Edition

Navigating the Digital Frontier

Read More
12 Grids

Navigating the Digital Frontier

FEATURING

    • Global Industry Trends & Insights
    • Global Events & Conferences
    • Market Insights & Trends
    • "In Talks With Leadership" featuring Dr. Ashok Kumar Bhattacharya
    • SMART Practices to Take Assistance of Generative AI to Respond to FDA Warnings 
Read Now

Other Articles from Magazine

12 Grids

Merck's WELIREG® Gains Priority FDA Review for Rare Tumors

Pg 14

12 Grids

Roche’s PATHWAY HER2 Test Gains FDA Approval For HER2-Ultralow Breast Cancer

Pg 14

12 Grids

Telix Receives European Approval for Prostate Cancer Imaging Agent

Pg 14

12 Grids

PM Modi Addresses Completion Of Indian Genome Project, Boosting Healthcare And Precision

Pg 15